BFLY vs LNTH vs VREX Stock Comparison

Butterfly Network, Lantheus Holdings and Varex Imaging Prices as of Nov 13, 2026 Peers: Industry group
BFLY Butterfly Network, Inc.
$6.09 -19.9% 1M +194.2% 1Y
Market cap
$1.54B
P/E
–
Revenue (TTM)
$123.25M
Div. yield
–
Diagnostic Equipment Healthcare
2 wins
LNTH Lantheus Holdings, Inc.
$101.59 +1.6% 1M +91.2% 1Y
Market cap
$6.65B
P/E
24.6x
Revenue (TTM)
$1.56B
Div. yield
–
Diagnostic Equipment Healthcare
9 wins
VREX Varex Imaging Corp
$18.10 -1.6% 1M +50.6% 1Y
Market cap
$766.85M
P/E
34.7x
Revenue (TTM)
$865.00M
Div. yield
–
Diagnostic Equipment Healthcare

Head to Head

11 decided of 12

Lantheus Holdings leads on 9 of the 12 questions below (Lantheus Holdings 9, Butterfly Network 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBFLYLNTHVREXLeader
Larger companyMarket capitalisation $1.54B $6.65B $766.85M LNTH
Cheaper on earningsLower P/E, profitable companies only -28.7x 24.6x 34.7x LNTH
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 17.4x 20.8x LNTH
Faster revenue growthRevenue growth, trailing twelve months +39.4% +2.4% +4.1% BFLY
More profitableNet margin, trailing twelve months -43.6% 17.3% 2.6% LNTH
Better return on capitalReturn on invested capital -30.5% 12.0% 6.9% LNTH
Less leveragedLower net debt / EBITDA 2.3x -0.3x 2.5x LNTH
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +194.2% +91.2% +50.6% BFLY
Better 5-year returnAnnualised price return, 5 years -6.7%/yr +27.3%/yr -8.1%/yr LNTH
Less volatileAnnualised volatility, 1 year 112.2% 30.1% 56.9% LNTH
Higher overall scoreMean of the five percentile scores vs peers 53/100 80/100 58/100 LNTH

Percentile Scorecard

BFLYLNTHVREX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBFLYLNTHVREX
Valuation 31 #167 of 243 79 #53 of 243 86 #36 of 243
Growth 88 #28 of 228 70 #70 of 228 19 #184 of 228
Profitability 39 #137 of 222 96 #11 of 222 66 #76 of 222
Financial Health 68 #81 of 248 69 #77 of 248 41 #146 of 248
Shareholder Returns 41 #94 of 158 85 #24 of 158 76 #38 of 158
Overall 53 80 58
  • BFLY ranked among 252 companies in Medical Devices and Diagnostics
  • LNTH ranked among 252 companies in Medical Devices and Diagnostics
  • VREX ranked among 252 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBFLYLNTHVREXSPY
1 month -19.9%+1.6%-1.6% -2.0%
3 months -31.1%+0.6%-2.1% -2.8%
6 months +59.0%+8.2%+87.4% +2.0%
Year to date +60.3%+52.7%+55.4% +10.6%
1 year +194.2%+91.2%+50.6% +12.2%
3 years +399.2%+48.6%-6.7% +68.1%
3 years, per year +71.0%+14.1%-2.3% +18.9%
5 years -29.2%+233.7%-34.3% +61.4%
5 years, per year -6.7%+27.3%-8.1% +10.1%
10 years —+931.4%— +248.5%
10 years, per year —+26.3%— +13.3%

Risk

MeasureBFLYLNTHVREXSPY
Volatility, 1Y 112.2%30.1%56.9% 13.6%
Downside volatility, 1Y 93.8%24.5%48.9% 13.9%
Beta vs S&P 500, 1Y 2.990.470.91 1.00
Return / volatility, 1Y 1.733.040.89 0.90
Max drawdown, 5Y -92.2%-59.5%-78.8% -25.4%
From 52-week high -38.7%-8.4%-2.6% -3.2%
52-week high $9.94$110.94$18.58 $779.14
52-week low $1.97$52.50$9.32 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBFLYLNTHVREX
P/E now vs peer median -30.2xmedian 26.5x 24.6xmedian 26.5x 34.5xmedian 26.5x
P/S now vs peer median 13.2xmedian 2.7x 4.3xmedian 2.7x 0.9xmedian 2.7x
EV/EBITDA now vs peer median -29.5xmedian 18.4x 16.9xmedian 18.4x 10.0xmedian 18.4x
P/FCF now vs peer median -58.9xmedian 25.4x 16.9xmedian 25.4x -37.8xmedian 25.4x
P/B now vs peer median 8.8xmedian 2.5x 4.9xmedian 2.5x 1.5xmedian 2.5x
PEG now vs peer median -1.00median 0.98 0.64median 0.98 -8.99median 0.98

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBFLYLNTHVREX
Revenue $123.25M $1.56B $865.00M
Gross profit $86.60M $957.06M $296.90M
Operating income -$57.83M $290.93M $72.20M
Net income -$53.69M $269.91M $22.40M
Free cash flow -$27.55M $393.09M -$20.20M
R&D $39.57M $217.83M $91.40M
EPS (diluted) $-0.20 $3.95 $0.52
Cash & equivalents $122.30M $683.61M $99.20M
Total debt $2.92M $571.74M $347.10M
Shares (diluted) 266.50M 68.41M 42.60M
Enterprise value $1.00B $4.51B $298.65M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBFLYLNTHVREX
P/E -30.2x 24.6x 34.5x
P/FCF -58.9x 16.9x -37.8x
P/Operating cash flow -69.4x 16.2x 67.5x
P/S 13.2x 4.3x 0.9x
P/B 8.8x 4.9x 1.5x
P/Tangible book 9.1x 9.3x 1.5x
EV/EBITDA -29.5x 16.9x 10.0x
EV/EBIT -26.0x 22.5x 14.0x
EV/Revenue 12.2x 4.2x 1.2x
EV/FCF -54.6x 16.6x -50.0x
EV/Operating cash flow -64.3x 16.0x 89.4x
PEG (3Y EPS CAGR) -1.00 0.64 -8.99

Growth

14 metrics
MetricBFLYLNTHVREX
Revenue growth (1Y) 39.4% 2.4% 4.1%
Revenue CAGR (3Y) 21.7% 9.0% -1.2%
Gross profit growth (1Y) 126.4% 0.8% -36.6%
Gross profit CAGR (3Y) 30.5% 13.9% 1.2%
Operating income growth (1Y) 33.5% -16.3% 562.8%
Operating income CAGR (3Y) 26.9% 73.7% -2.3%
Net income growth (1Y) 32.8% 61.0% 112.3%
Net income CAGR (3Y) 24.2% 37.4% -9.2%
EPS growth (1Y) 36.4% 59.2% 111.8%
EPS CAGR (3Y) 30.4% 38.5% -3.8%
Operating cash flow growth (1Y) 5.8% -10.5% -88.4%
Operating cash flow CAGR (3Y) 41.1% 11.1% -42.0%
Free cash flow growth (1Y) -0.1% -5.1% -119.2%
Free cash flow CAGR (3Y) 38.8% 119.0% -75.7%

Profitability

14 metrics
MetricBFLYLNTHVREX
Gross margin 70.3% 61.3% 34.3%
EBITDA margin -41.4% 24.7% 11.7%
Operating margin -46.9% 18.6% 8.3%
Pretax margin -43.5% 21.9% 3.2%
Net margin -43.6% 17.3% 2.6%
FCF margin -22.4% 25.2% -2.3%
Operating cash flow margin -19.0% 26.2% 1.3%
Return on equity -28.7% 20.2% 4.5%
Return on assets -18.8% 11.1% 2.1%
Return on invested capital -30.5% 12.0% 6.9%
Return on capital employed -26.6% 13.9% 8.0%
Asset turnover 0.4x 0.6x 0.8x
Cash conversion (OCF / net income) 0.4x 1.5x 0.5x
Stock comp / revenue 20.8% 4.8% 1.7%

Financial Health

11 metrics
MetricBFLYLNTHVREX
Debt / assets 1.0% 23.3% 31.6%
Debt / equity 0.0x 0.4x 0.7x
Net debt / EBITDA 2.3x -0.3x 2.5x
Debt / FCF -0.1x 1.5x -17.2x
Liabilities / assets 36.0% 44.8% 53.6%
Equity / assets 64.0% 55.2% 46.4%
Interest coverage -46.8x 14.7x 1.9x
Current ratio 3.6x 3.2x 3.4x
Quick ratio 2.3x 3.0x 1.3x
Cash ratio 1.8x 2.0x 0.5x
Altman Z-score 5.44 5.54 2.27

Shareholder Returns

7 metrics
MetricBFLYLNTHVREX
Dividend yield – – –
Net buyback yield -0.5% 1.3% 0.1%
Shareholder yield -0.5% 1.3% 0.1%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBFLYLNTHVREX
Forward P/E – 17.4xFY2026 20.8xFY2026
EPS, next fiscal year $-0.06FY2026 $5.83FY2026 $0.87FY2026
EPS growth, next FY – -4.1%FY2026 -3.3%FY2026
EPS growth, the year after – +7.2% +14.9%
Revenue, next fiscal year $117.62MFY2026 $1.58BFY2026 $829.68MFY2026
Revenue growth, next FY +20.5%FY2026 +2.5%FY2026 -1.8%FY2026
Revenue growth, the year after +22.7% +12.6% +2.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBFLYLNTHVREX
Held by institutions 58.4% 100.0% 95.2%
Institutions holding 248 468 188
Change in shares held, QoQ +13.9% +3.4% -2.7%
Institutions buying 144 249 100
Institutions selling 59 143 58
Buyers to sellers 2.44 1.74 1.72

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BFLYLNTHVREX
BFLY 1.00 0.08 0.18
LNTH 0.08 1.00 0.15
VREX 0.18 0.15 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BFLY, LNTH and VREX?

Lantheus Holdings (LNTH) is the largest by market capitalisation: Butterfly Network (BFLY) $1.54B, Lantheus Holdings (LNTH) $6.65B, Varex Imaging (VREX) $766.85M.

Which stock is cheaper, BFLY, LNTH and VREX?

Lantheus Holdings (LNTH) trades on the lowest price-to-earnings ratio (Butterfly Network (BFLY) -28.7x, Lantheus Holdings (LNTH) 24.6x, Varex Imaging (VREX) 34.7x). On next year's consensus earnings, Lantheus Holdings (LNTH) is cheapest (Lantheus Holdings (LNTH) 17.4x, Varex Imaging (VREX) 20.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Butterfly Network (BFLY) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +39.4%, Lantheus Holdings (LNTH) +2.4%, Varex Imaging (VREX) +4.1%.

Which company is more profitable?

Lantheus Holdings (LNTH) has the highest net margin (Butterfly Network (BFLY) -43.6%, Lantheus Holdings (LNTH) 17.3%, Varex Imaging (VREX) 2.6%). On return on invested capital, Lantheus Holdings (LNTH) leads (Butterfly Network (BFLY) -30.5%, Lantheus Holdings (LNTH) 12.0%, Varex Imaging (VREX) 6.9%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Butterfly Network (BFLY) +194.2%, Lantheus Holdings (LNTH) +91.2%, Varex Imaging (VREX) +50.6%. Over five years, Lantheus Holdings (LNTH) compounded fastest (Butterfly Network (BFLY) -6.7%/yr, Lantheus Holdings (LNTH) +27.3%/yr, Varex Imaging (VREX) -8.1%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Lantheus Holdings (LNTH) has been the steadiest (Butterfly Network (BFLY) 112.2%, Lantheus Holdings (LNTH) 30.1%, Varex Imaging (VREX) 56.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BFLY, LNTH and VREX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Lantheus Holdings (LNTH) leads on 9. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.